INDIA ,  Poliomielite da vaccino 
Ecco il recente studio che ha coinvolto più di 17.000 bambini fino a 19 anni
Questo studio-indagine attualmente in corso è stato avviato dall’omeopata Andreas Bachmair.
20 FATTI misconosciuti sui Vaccini + Perche' vaccinare ? + I miti dei Vaccini
La scomparsa delle malattie infettive NON e' dovuta ai vaccini ! (Francais)
Premi in denaro ai medici che vaccinano...
 

CALCUTTA - Mon. 12 Nov 2001 - vedi anche: Altri gravi casi a decine di migliaia di bambini rovinati dai vaccini

Almeno 10 bambini sono morti nello stato dell'India Nord-Orientale di Assam per effetti collaterali, dopo la somministrazione del vaccino durante una campagna di immunizzazione della polio, indetta dal Governo. Più di 500 bambini si ammalarono e furono ammessi in ospedali governativi e privati. Gruppi di parenti circondarono gli uffici dell'amministrazione locale per protestare, in Assam, una città al sud di Silchar
La domenica, in Assam e nella restante Nazione, a migliaia di bambini fu somministrato il vaccino "Polio", ma entro un giorno dalla massiccia campagna di vaccinazione per la "Polio", arrivarono rapporti a larga scala, degli effetti collaterali, nella città di Assam e nel Silchar. 
I funzionari dicono che in un villaggio, Labok 9 bambini sono morti e 1 nel Malugram, località del Silchar.
Organizzazioni non governative, che assistono il Governo in questa campagna, dicono che probabilmente in alcune aree sono stati inviati vaccini antiquati, ma i funzionari non volevano speculare, su larga scala, sulle cause degli effetti collaterali.

Poliomielite da vaccino - India: post-vaccination 20001220.2234  - Poliomyelitis, suspected
 – 0600 - Henry V. Huang - BBC News Online, Mon 12 Nov 2001 [edited

http://news.bbc.co.uk/hi/english/health/newsid_1651000/1651863.stm

INDIA - vedi anche QUI .....  e QUI - vedi: i vaccini diffondono le malattie

In INDIA DOPO le grandi campagne di vaccinazione per la poliomielite, dell'OMS, Bill Gates e Rockefeller, e', cosi dicono, le autorita' ufficiali, colluse con Big Pharma..., ricomparsa la polio....pero' dicono che e' la conseguenza, la colpa di un  virus detto "selvaggio" (non  addomesticato....ha...ha...ha...) pur di non accettare la verita' = sono le vaccinazioni di massa che propagano la Poliomielite !
Sono i vaccini per la polio che hanno utilizzato nelle campagne di vaccinazione in INDIA e paesi del terzo mondo (OMS + Bil Gates + Rockefeller & C....) che diffondono e propagano la polio e danno la colpa al "virus selvaggio" !....questo ....perche' Bill Gates e' stato messo sotto processo in India per strage - paralisi e morti, per la campagna di vaccinazione per la polio, che ha finanziato direttamente con la sua fondazione ! ....che BUGIARDI, CRIMINALI....
Tenete presente che quella tossina virale per la polio e' endemica negli intestini delle popolazioni del terzo mondo e sui soggetti malnutriti od immunodepressi dai vaccini che hanno subito in precedenza, queste tossine virali, producono molti e qualsiasi possibili danni....dalle disfunzioni dello sviluppo, autismo, allergie alle paralisi e morte !
Nei paesi del terzo mondo utilizzano un vaccino per sterilizzare le femmine ! - vedi: Contenuto dei Vaccini

L’Immunità di gregge, è la supposta carta vincente per la difesa della vaccinazione in TV, Internet, riviste mediche e giornali, sul motivo per cui dovremmo essere vaccinati più e più volte per tutta la vita, con un numero sempre crescente di vaccini e cio' per ogni malattia.
Lo sbandierato a 360° "supposto successo delle vaccinazioni" è basato fondamentalmente su "teorie" che si danno per scontate, senza controllarle. Quando si entra nei particolari si evince e si dimostra invece che il tasso di incidenza e di morte di molte malattie infettive, è diminuito radicalmente nel e dal momento in cui si registrava un miglioramento delle condizioni, igienico-sanitarie, abitative, alimentari e delle procedure di isolamento,
Pero' siccome nello stesso periodo sono stati introdotti i vaccini, la medicina ufficiale ha dato per scontato che la sola vaccinazione sia stata interamente responsabile della scomparsa di queste "malattie" e per far quadrare questa teoria fasulla, ha cambiato nome alle malattie.....QUI in queste pagine ve ne daremo la dimostrazione !

vedi: Morbosità e Mortalità DOPO la vaccinazione per la poliomielite in Assam + Falsita' della medicina ufficiale  +  1000 studi sui Danni dei Vaccini  +  Come distruggere in maniera scientifica il sistema immunitario, con i Vaccini + Perche' vaccinare ?

Meno si vaccina, meno morti ci sono !
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170075/
http://www.ncbi.nlm.nih.gov/pubmed/21543527 
https://vactruth.com/vaccines-and-mortality-rates/

IMPORTANTE: questo pdf: http://www.dipmat.unipg.it/~mamone/sci-dem/nuocontri_1/debernardi.pdf
Morbidity and Mortality after Polio vaccination in Assam
CALCUTTA: At least 10 children have died in India's northeastern state of Assam of side effects after being administered a vaccine during an polio immunisation campaign run by the state government. More than 500 children have been admitted to government and private hospitals after falling sick.
Angry groups of parents have surrounded offices of the local administration in protest in Assam's southern city of Silchar.
On Sunday, thousands of children were administered a Polio vaccine throughout Assam and the rest of the country. 
But within a day of the massive polio immunisation campaign, reports have come in of large-scale side effects in and around the city of Silchar in southern Assam. Officials say 9 children have died in one village -- Labok -- while one died in Malugram locality of Silchar.
Non-governmental organisations in Silchar who assist the government in this campaign say outdated vaccines were possibly supplied in some areas. But officials were not willing to speculate on the causes of the large-scale side effects. 
[Byline: Subir Bhaumik]

Henry V. Huang Dept. of Molecular Microbiology Washington U. School of Medicine - 
Box 8230, 660 S. Euclid Avenue - St. Louis, MO 63110-1093 USA - huang@borcim.wustl.edu

Argentina - India  - 21/08/2008  - VACCINAZIONI: MORTI BIMBI cavia in Argentina ed India
12 Bambini sono stati uccisi in pochi mesi mentre erano sottoposti ad un ciclo di vaccinazioni con un nuovo tipo di vaccino sperimentale della multinazionale GlaxoSmithKline dagli inizi del 2007 - su 15.000 vaccini (per il pneumococco) oltre a questi morti (alla data del 01/06/2008) altre centinaia si sono ammalati di varie malattie.

Le autorita' statali hanno immediatamente sospeso le campagne vaccinali effettuate con il loro permesso dalla GlaxoSK ed hanno avviato un' indagine; i genitori dei morti e degli ammalati, di umili origini, avevano firmato senza sapere che si trattava di sperimentazione in fase tre. La sperimentazione sta continuando in Colombia e Panama...con la collusione delle autorita' locali...
Ovviamente la casa farmaceutica nega che vi siano correlazioni fra le morti e gli ammalamenti dei bambini ed i vaccini propinati e sta preparandosi legalmente per difendersi dai processi a loro intentati dalle poche famiglie che hanno il denaro e la forza per richiedere GIUSTIZIA !

In India i morti sono fino ad ora 49 ed le aziende coinvolte sono la Novartis e la Roche le quali hanno sperimentato nuovi farmaci e vaccini, promettendo somme di denaro ai genitori firmatari che accettavano di sottoporre i loro figli, su un quantitativo di 4.142 bambini, con l'autorizzazione del Ministero della sanita'.
Attualmente in India sono in corso 139 sperimentazioni in tutto il paese con un giro di affari di 200 milioni di $. Da qui al 2010 il giro d'affari aumentera' ad 1 miliardo di dollari !
Tratto in parte da aduc.it/salute

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

SMALLPOX VACCINE, WHO STATEMENT - Date: Tue 22 Oct 2001 - From: Jaime R. Torres, ProMED-ESP - Source: BBC Mundo [edited]; [translated by MJ
http://news.bbc.co.uk/hi/spanish/science/newsid_1613000/1613692.stm

WHO Statement on Smallpox Vaccination Policy
The World Health Organization, WHO, stated that it is reconsidering using the vaccine against smallpox, in light of the possible use of the virus as a biological weapon. Smallpox is considered to have been officially eradicated in 1980. 
For years, there have been no cases reported. Nonetheless, because of the potential for the use of the virus in terrorist actions, WHO has decided to include it in the list of 11 diseases that might be used by extremist groups.
Ian Simpson, spokesman for the organization, stated that WHO's recommendation to governments is that they verify their level of preparedness to handle diseases, including smallpox. The resurgence of fear related to smallpox was prompted by the cases of anthrax in the US.
However, unlike anthrax, smallpox is a highly contagious disease among humans. Nonetheless, the vaccine may be effective in preventing or reducing the severity of the clinical disease, up until 4 days after the person has been infected. Contrary to popular belief, the immunity conferred by the vaccine is not for life and, in many cases, it is necessary to administer booster doses every 5 to 10 years in order to maintain protective levels of neutralizing antibodies.

WHO calculates that there are close to 90 million doses of the vaccine stored by governments for use in civilian 
populations. However, manufacture of the vaccine involves a complex procedure and some specialists affirm that it is probable that the WHO will maintain its recommendations against massive vaccination.
For the time being, although there are no indications of a possible terrorist act with the smallpox virus, the United States has begun to multiply its vaccine reserves, according to a multi-tiered plan that even contemplates immunizing the entire population of the country.
Some scientists calculate that a massive vaccination campaign could take months, even years, and that by the time of its conclusion, the threat may well have vanished.
ProMED-mail - promed@promedmail.org

[Smallpox vaccine -- which is made from vaccinia & not smallpox virus -- saved many more lives than those who died from adverse reactions. The major problem with restarting mass vaccination in the absence of disease is that adverse reactions will kill some people -- perhaps many in this age of AIDS & lowered immunity. Remember the swine flu vaccine problems ? - Mod.JW]

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

SMALLPOX VACCINE, WHO STATEMENT (02)
Date: Fri 26 Oct 2001 - From: Daniel B. Epstein (WDC) - epsteind@paho.org - epsteind@paho.org
Source: Statement WHO/16, Fri 26 Oct 2001 [edited] http://www.who.int/inf-pr-2001/en/state2001-16.html

Statement to the Press by the Director-general of the WHO, Dr Gro Harlem Brundtland: World Health Organization Announces Updated Guidance on Smallpox Vaccination

GENEVA: Following the review of guidance on smallpox vaccination I announced last week, WHO has consulted with our advisory committee and has updated the official guidance. The conclusion of the review states that: "Existing vaccines have proven efficacy but also have a high incidence of adverse side-effects. 
The risk of adverse events is sufficiently high that mass vaccination is not warranted if there is no or little real risk of exposure. Individual countries that have reason to believe that their people face an increased risk of smallpox because of deliberate use of the virus are considering options for increasing their access to vaccines.
The vaccines would be given to people who are at risk of exposure to smallpox, including health and civil workers, and would be used in a search and containment exercise should an outbreak occur.

In summary, the guidance is that vaccination of entire populations is not recommended. The reason for not recommending such mass vaccination is that there is a risk of severe reactions to the vaccine, *including death*, and the fact that vaccination can prevent smallpox even after exposure to the virus.
Up to now the guidance has also stated that only those with suspected exposure to smallpox or a related virus should be vaccinated. That has not changed. What has changed is the increasing attention being given to the extent and quality of existing vaccine stocks, and to the possible need both to stimulate vaccine production and increase stocks of vaccine for use in the event of an outbreak. WHO confirms that the best method of stopping a smallpox outbreak, should it occur, remains the same -- search and containment. That means identifying persons with smallpox, identifying those people who have been in contact with them, and vaccinating them.

*People who have been vaccinated in the past are unlikely to develop the most serious effects of smallpox.*
This advice and background information on smallpox is now being made available to governments through the WHO - web-site: http://www.who.int>www.who.int

Along with this advice we are providing Frequently asked Questions and Answers about smallpox and a smallpox Fact Sheet with an electronic slide set of training materials on smallpox.

Other information that will be provided to Health Ministers on request includes a list of vaccine manufacturers that have the potential to produce smallpox vaccine and the names of laboratories that can diagnose smallpox. WHO has also re-established a team of technical experts in smallpox who are available to assist countries in the investigation and response to outbreaks.

Finally, I want to emphasize that should an outbreak of smallpox be detected in any country, this should be considered an international emergency. WHO will help countries to pool available resources so as to contain the disease as rapidly and effectively as possible."

Daniel Epstein - Information Officer  Pan American Health Organization/World Health Organization 525 23rd St., 
NW - Washington D.C. 20037 - (by "BBC News Online", Mon 22, 26 Oct e 12 Nov 2001)  

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Il vaccino Sabin (quello della Polio) miete vittime in Repubblica Dominicana e nelle Filippine
Il virus contenuto nel vaccino della polio, liberatosi nell'ambiente a causa della vaccinazione di massa con il vaccino Sabin, ha fatto solo nell’anno 2000, 19 vittime nella Repubblica Dominicana, che hanno riportato la polio paralitica a causa dell'infezione procurata dal virus “sabin”.
Fra marzo e luglio 2001, altri 3 casi si sono verificati nelle Filippine.
(vedi "Mortality and Morbidity Weekly Report", 12 ottobre 2001/50(40); 874-5).
Le 3 persone erano state vaccinate in precedenza contro la polio.  E’ emerso quindi chiaramente che la vaccinazione non copre dal virus del vaccino Sabin.

Vaccinando con il Sabin (il vaccino orale con virus vivo attenuato in formalina, prodotto notoriamente cancerogeno) in paesi dove non esiste un sistema fognario che divida le acque di scarico da quelle domestiche il virus vaccinico della polio viene reimmesso nell'ambiente attraverso le feci.
Anche stavolta il virus del vaccino sabin è rimasto latente nell'ambiente per un periodo sufficientemente lungo di tempo per acquisire modificazioni genetiche e riacquistare neurovirulenza,  producendo nuovi casi di malattia in soggetti già vaccinati.
Ugualmente  è accaduto anche in Africa per l’Aids……..scatenato dalle campagne vaccinali del decennio degli anni 70’
Siamo infatti di fronte ad un ulteriore nuovo e mutato virus (il sabin), alla cui origine vi è esclusivamente la colpa umana della cosiddetta “scienza medica”, manipolatrice di virus altamente pericolosi; di fatto trattasi di guerra batteriologica…...  
La celebre rivista medica Lancet già un anno ha invitato ad abbandonare il Sabin e vaccinare solo con Salk per non 
peggiorare la situazione.
Invece il governo filippino ha deciso di iniziare una nuova campagna di vaccinazione di massa con il Sabin…….le scorte di vaccino delle multinazionali……hanno “convinto” qualche ministro…..ad ignorare i fatti ed a smaltire quei vaccini pericolosi che sono stati inoculati, lo ricordiamo. anche su oltre 450 milioni di europei; il vaccino sabin è stato contaminato da un altro virus scimmiesco lo SV 40 concausa del cancro chiamato “mesiotelioma” dagli anni 50’ fino agli anni 80’ !!!

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Dall'International Society for Infectious Diseases. - POLIOMYELITIS, VACCINE - DERIVED - PHILIPPINES: 2001
[see also: Poliomyelitis - Dominican Republic & Haiti 20011005.2415 - Polio, circulation of vaccine-derived  virus 20010129.0205

2000
-------
Poliomyelitis - Dominican Rep.: control measures 20001218.2212
Poliomyelitis - Dominican Republic & Haiti: ALERT 20001202.2098
Poliomyelitis - Dominican Republic & Haiti: background 20001203.2102
Poliomyelitis - Dominican Republic & Haiti: comment 20001204.2110
Poliomyelitis - Dominican Republic & Haiti: update 20001208.2149
Poliomyelitis - Dominican Republic: visitor advice 20001215.2195]

Date: 12 Oct 2001
From: ProMED-mail mailto:promed@promedmail.org - promed@promedmail.org
Source: MMWR 50(40);874-5 [edited]
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5040a3.htm
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5040a3.htm

Public Health Dispatch: Acute Flaccid Paralysis Associated with Circulating Vaccine-Derived Poliovirus --- Philippines, 2001

Three cases of acute flaccid paralysis (AFP) associated with circulating vaccine-derived poliovirus (cVDPV) isolates were reported in the Philippines during March 15--July 26, 2001. The first case-patient, a child aged 8 years from northern Mindanao island (500 miles south of Manila) who had received 3 doses of oral polio vaccine (OPV), had onset of paralysis on March 15. A second child, aged 3 years from Laguna province on Luzon island (60 miles south of Manila) who had received 3 OPV doses, presented with signs of meningitis but no paralysis on July 23. A third child, aged 14 months from Cavite province (25 miles from Manila and 45 miles north of Laguna province) who had received 2 OPV doses, had onset of paralysis on July 26. No patients had traveled outside of their province of residence since birth. Characterization of isolates from the 3 patients revealed type 1 polioviruses derived from Sabin vaccine strain type 1, with a 3% genetic sequence difference between Sabin 1 vaccine and vaccine-derived poliovirus (VDPV) isolates. The 3 polioviruses are not identical but are closely related (99% sequence homology); they also appear to share an identical recombination site with a nonpolio enterovirus in the noncapsid
region of the genome. 

Following cVDPV outbreaks in the Dominican Republic and Haiti (Hispaniola) during 2000--2001 (1), the global polio laboratory network implemented additional testing requirements for all polioviruses under investigation, prospectively and retrospectively. Both an antigenic-based (ELISA) and a molecular-based test (probe hybridization) are used to determine whether a poliovirus is wild or derived from vaccine (i.e., intratypic differentiation [ITD]). Divergent ITD results (one test showing vaccine-derived and the other wild-type virus) for any poliovirus isolate now require genomic sequencing of the suspect isolates. Retrospective testing of 2000 vaccine-related isolates from AFP cases globally has revealed no additional cVDPVs, although testing results of other isolates in the laboratory network are pending. The cVDPVs from the Philippines were detected after the implementation of new testing requirements for prospective virus investigations.

In response to these cases, the Department of Health in the Philippines 
1) enhanced surveillance by active record review for AFP cases in hospitals and other health-care facilities in the affected and neighboring provinces, 
2) established surveillance to conduct virologic investigations of aseptic meningitis at major health-care facilities, 3) collected stool samples from healthy contacts of case-patients, 
4) conducted field investigations of clustered AFP cases to determine the extent of cVDPV circulation, and 
5) assessed polio vaccination coverage in these communities. The investigations have found no unreported cases, although some AFP cases remain under investigation. To interrupt cVDPV circulation, a large-scale mass vaccination campaign with OPV is planned. 
Low routine vaccination coverage is one of the most important causes of VDPV. Because the location of the originating events is unknown, the contribution of other factors is difficult to assess; however, a combination of 2 concurrent events within the virus is necessary for cVDPV emergence: reversion of attenuating mutations to increase neurovirulence, and a presumed increase in transmission characteristics that might be related to recombination with a nonpolio enterovirus. 
The molecular basis for the second property is not understood.

Wild poliovirus was last reported in the Philippines in 1993 (2), and national vaccination rounds were last conducted in the Philippines in 1997 followed by subnational immunization days in 1998 and 1999. 
Among the areas covered were Cebu, Davao, Manila, and parts of Mindanao; however, coverage did not extend to the 3 provinces now reporting cVDPV cases. Routine coverage with 3 OPV doses has been approximately 80% nationwide since the early 1990s; however, coverage gaps are likely, particularly in slum areas.

Travelers to the Philippines should ensure that they are vaccinated appropriately against polio according to national recommendations (3). 

Reported by: National Epidemiology Center, National Center for Disease Prevention and Control, Research Institute of Tropical Medicine, Dept of Health; World Health Organization, Manila, Philippines. Regional Reference Laboratory, Victorian Infectious Diseases Reference Laboratory, Fairfield, Victoria, Australia. Global Specialized Laboratory, National Institute of Infectious Diseases, Tokyo, Japan. Vaccines and Biologicals Dept, World Health Organization, Geneva, Switzerland. Respiratory and Enteric Viruses Br, Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases; Vaccine Preventable Disease Eradication Div, National Immunization Program, CDC.

References
CDC update: outbreak of poliomyelitis---Dominican Republic and Haiti, 2000--2001. MMWR 2001;50:855--6.
CDC. Progress toward poliomyelitis eradication---Western Pacific Region, January 1, 1996--September 27, 1997. MMWR 1997;46:1113--7. 
CDC. Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices. MMWR 2000;49(no. RR-5). 

ProMED-mail: mailto:promed@promedmail.org>promed@promedmail.org 

[This is now the third documented episode of poliomyelitis-like illness (acute flaccid paralysis - AFP) due to circulating vaccine derived poliovirus (cVDPV) with reversion to neurovirulence. The 2 prior episodes were on the island of Hispaniola (Dominican Republic and Haiti) and in Egypt (see referenced ProMED-mail postings above). 
In addition, there were reports of circulating vaccine derived poliovirus in Israel identified in sewage sampling but not associated with clinical illness (also reported in above ProMED-mail postings).

One wonders if this is a case of "seek and ye shall find" or if this is an emerging problem associated with the disease. The former seems to be preliminarily ruled out by the failure of a retrospective study of over 2000 AFP associated poliovirus isolates to identify additional VDPV, albeit if it is a low level occurrence, we may miss it by virtue of the rarity of the event. If the latter is the case, one wonders why now, after approximately 50 years of use are we seeing this phenomenon. If one rejects the reference of "approximately 50 years of use" and chooses to further refine the date to when increased vaccination activities associated with the polio eradication effort began, then the time frame for widespread use is approximately 16 years, when polio eradication activities in the Americas region began.

Of note is that this has occurred in 3 different regions of the world -- the Middle East (Egypt and Israel), the Americas (Hispaniola) and now in the Western Pacific (Philippines). In 2 areas (Hispaniola and the Philippines) circulation of the wild poliovirus had been interrupted (the last reported case of wild poliovirus associated disease in the Americas was in 1991 and in the Philippines in 1993). 

In the absence of total interruption of wild poliovirus circulation world-wide there is still a need to keep up intensified vaccination efforts as the risk of disease is still present, especially in today's environment with extensive travel world-wide. The occurrence of cVDPV in association with clinical disease is very disturbing as it adds another factor into the risk benefit equation of vaccination recommendations. As mentioned in an earlier comment, a cost-efficacy analysis of switching to the inactivated vaccine (inactivated polio vaccine - IPV) in countries that have interrupted wild virus circulation probably negates the economic viability of such a recommendation. In addition, and not an insignificant addition is that a switch to the IPV would remove the advantage of flooding the environment with the vaccine virus (the attenuated very low-neurovirulence virus) to further interrupt transmission of wild poliovirus if introduced as well as to "vaccinate" individuals who may not have directly taken the vaccine themselves. - 
Mod.MPP] ......mpp/cp/es
Tratto da:  VacciNetwork.org del 22.11.2001 (sito chiuso non si sa perche' ?)